SATURDAY, DECEMBER 3, 2016

New HIV infections in the US down, but well short of national goals

Researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health have reported that the number of new HIV infections and the rate of transmission in the United States has dropped by 11 and 17 percent between 2010 and 2015.  Read More »

Wistar Institute research suggests strategies for combating Chikungunya virus

A Wistar Institute study recommends combating Chikungunya virus (CHIKV) through boosting the immune system by rapidly producing CHIKV antibodies as well as a traditional DNA-based vaccine. Read More »

Scientists advance parameter selection, verification techniques in HIV model

In a paper recently published in SIAM Journal on Uncertainty Quantification, Mami Wentworth, Ralph Smith and H.T. Banks used robust parameter selection and verification techniques on a dynamic HIV model. Read More »

Chimpanzee parasite genomes show human malaria is evolving

An international team of scientists has implemented a selective amplification technique that allowed them to sequence genomes from two species of parasites in chimpanzees, helping them to better understand how human malaria has evolved over time. Read More »

Temple researchers erase HIV-1 from human T-cells

Scientists from Temple University's Lewis Katz School of Medicine recently developed a specialized gene editing system that can erase HIV-1 from human T-cells, potentially making a cure for patients with HIV infections. Read More »

ViiV Healthcare releases study results of HIV inhibitor

ViiV Healthcare, GSK's worldwide HIV specialist, recently released the positive results from its 41-week Phase IIa ÉCLAIR study to determine the tolerability, safety, satisfaction and dosing of an investigational monotherapy for potential HIV patients. Read More »

State laws heighten influenza vaccination rates among health care workers

A new study from the University of Pittsburgh School of Medicine shows that state laws requiring health care works to receive their influenza vaccines can raise the vaccination rates. Read More »

GSK seeks alternative to cold chain storage

GlaxoSmithKline (GSK) and Variation Biotechnologies, a subsidiary of VBI Vaccines Inc., recently finalized a partnership in which the company’s researchers will use a VBI technology called the LPV Platform. Read More »

Synthetic vaccine test shows immune response to Zika virus

Inovio Pharmaceuticals Inc. recently stated that its pre-clinical testing for the company’s synthetic vaccine designed to protect people from the Zika virus has shown a robust, durable immune response in test subjects. Read More »

GSK seeks approval to administer flu vaccine to children 6 months and older

Officials at GlaxoSmithKline (GSK) recently submitted the paperwork for a supplement Biologics License Application for the Flulaval Quadrivalent influenza vaccine to the Food and Drug Administration. Read More »

Scientists show efficiency of antiretroviral therapy for infants with HIV

Scientists in South Africa have surpassed missing data to show that antiretroviral therapy is effective in treating infants who have HIV infections. Read More »

FDA extends GSK's Hib vaccine to full series

The Food and Drug Administration recently took steps to extend the HIBERIX vaccine from GlaxoSmithKline from just a booster dose to a full series to better protect people from Haemophilus influenzae type b. Read More »

Novel model of SIR-Network predicts dengue epidemics

A new model of SIR-Networks, shown in an article titled “SIR-Network Model And Its Application To Dengue Fever,” shows that there will soon be dengue fever epidemics based within urban regions. Read More »

ViiV Healthcare purchases HIV assets from Bristol-Meyers Squibb

GlaxoSmithKline (GSK) PLC and ViiV Healthcare, its worldwide HIV vaccine and treatment business, recently finalized an agreement to purchase HIV assets from Bristol-Meyers Squibb. Read More »

Group seeks safer packing, larger label design for vaccines

The International Medication Safety Network (IMSN) recently released its position statement that urges the global health industry to create safer packaging and labeling for vaccines. Read More »

GlaxoSmithKline, Comic Relief partner to battle malaria

GlaxoSmithKline and Comic Relief have entered a five-year partnership to battle malaria and improve health systems around the world. Read More »

Malawi study shows AIDS treatments help more than HIV patients

A University of Pennsylvania study shows that AIDS treatments bring improved health and economic benefits to people who don’t have HIV. Read More »

Wistar studies resistance to HIV among some sex workers

Scientists from the Wistar Institute recently conducted a study evaluating whether there may be a correlation or connection between semen exposure and resistance to HIV infection among sex workers. Read More »

Pennsylvanians can receive low- or no-cost flu shots

The Pennsylvania Department of Health is offering eligible local residents either low or no-cost influenza vaccines through Friday. Read More »

HIV/AIDS treatments shown to disrupt cognitive function

Antiretroviral medications that are commonly part of treatments for HIV infections and AIDS were recently proved to interrupt the function of insulation known as oligodendrocytes that protect the brain. Read More »